ACCURAY INCORPORATED Interest Expense
ACCURAY INCORPORATED (ARAY) reported Interest Expense of $8.05 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-11-05
- ACCURAY INCORPORATED interest expense for the quarter ending 2025-09-30 was $8.05M, a 172.49% increase year-over-year.
- ACCURAY INCORPORATED interest expense for the quarter ending 2025-06-30 was $4.23M, a 45.93% increase year-over-year.
- ACCURAY INCORPORATED interest expense for the quarter ending 2025-03-31 was $2.89M, a 0.21% increase year-over-year.
- ACCURAY INCORPORATED interest expense for the quarter ending 2024-12-31 was $2.88M, a 1.33% decline year-over-year.
- ACCURAY INCORPORATED interest expense for fiscal 2025 was $12.95M, a 11.44% increase from fiscal 2024.
- ACCURAY INCORPORATED interest expense for fiscal 2024 was $11.62M, a 9.33% increase from fiscal 2023.
- ACCURAY INCORPORATED interest expense for fiscal 2023 was $10.63M, a 30.79% increase from fiscal 2022.
- ACCURAY INCORPORATED interest expense for fiscal 2022 was $8.13M, a 51.88% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $8.05M 10-Q · filed 2025-11-05 | $12.28M derived: sum of 2 quarters · filed 2025-11-05 | $15.17M derived: sum of 3 quarters · filed 2025-11-05 | $18.05M derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-28 | $7.12M derived: sum of 2 quarters · filed 2025-08-28 | $10.00M derived: sum of 3 quarters · filed 2025-08-28 | $12.95M 10-K · filed 2025-08-28 |
| 2025-03-31 | $2.89M 10-Q · filed 2025-05-02 | $5.77M derived: sum of 2 quarters · filed 2025-05-02 | $8.73M 10-Q · filed 2025-05-02 | $11.62M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | $2.88M 10-Q · filed 2025-02-05 | $5.84M 10-Q · filed 2025-02-05 | $8.73M derived: sum of 3 quarters · filed 2025-11-05 | $11.62M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-09-30 | $2.96M 10-Q · filed 2025-11-05 | $5.85M derived: sum of 2 quarters · filed 2025-11-05 | $8.73M derived: sum of 3 quarters · filed 2025-11-05 | $11.66M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-28 | $5.78M derived: sum of 2 quarters · filed 2025-08-28 | $8.70M derived: sum of 3 quarters · filed 2025-08-28 | $11.62M 10-K · filed 2025-08-28 |
| 2024-03-31 | $2.88M 10-Q · filed 2025-05-02 | $5.81M derived: sum of 2 quarters · filed 2025-05-02 | $8.73M 10-Q · filed 2025-05-02 | $11.73M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $2.92M 10-Q · filed 2025-02-05 | $5.84M 10-Q · filed 2025-02-05 | $8.85M derived: sum of 3 quarters · filed 2025-02-05 | $11.57M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | $2.92M 10-Q · filed 2024-11-06 | $5.92M derived: sum of 2 quarters · filed 2024-11-06 | $8.65M derived: sum of 3 quarters · filed 2024-11-06 | $11.29M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $5.73M derived: sum of 2 quarters · filed 2024-09-19 | $8.37M derived: sum of 3 quarters · filed 2024-09-19 | $10.63M 10-K · filed 2024-09-19 |
| 2023-03-31 | $2.72M 10-Q · filed 2024-05-08 | $5.37M derived: sum of 2 quarters · filed 2024-05-08 | $7.63M 10-Q · filed 2024-05-08 | $9.66M derived: sum of 4 quarters · filed 2024-09-19 |
| 2022-12-31 | $2.64M 10-Q · filed 2024-02-07 | $4.91M 10-Q · filed 2024-02-07 | $6.94M derived: sum of 3 quarters · filed 2024-09-19 | $8.92M derived: sum of 4 quarters · filed 2024-09-19 |
| 2022-09-30 | $2.26M 10-Q · filed 2023-11-07 | $4.29M derived: sum of 2 quarters · filed 2024-09-19 | $6.28M derived: sum of 3 quarters · filed 2024-09-19 | $8.35M derived: sum of 4 quarters · filed 2024-09-19 |
| 2022-06-30 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $4.01M derived: sum of 2 quarters · filed 2024-09-19 | $6.09M derived: sum of 3 quarters · filed 2024-09-19 | $8.13M 10-K · filed 2024-09-19 |
| 2022-03-31 | $1.98M 10-Q · filed 2023-05-08 | $4.06M derived: sum of 2 quarters · filed 2023-05-08 | $6.10M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $2.08M 10-Q · filed 2023-02-02 | $4.12M 10-Q · filed 2023-02-02 | ||
| 2021-09-30 | $2.04M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $16.89M 10-K · filed 2023-09-07 | |||
| 2020-06-30 | $18.08M 10-K · filed 2022-08-17 | |||
| 2019-06-30 | $15.08M 10-K · filed 2021-08-17 | |||
| 2018-06-30 | $14.96M 10-K · filed 2020-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |